FONT-SIZE Plus   Neg

Pre-market Movers For Feb 27 (TGT, DLTR, OPTR, PCLN, FSLR, FDML)


Dollar Tree, Inc. (DLTR) is rising 4 percent to $42.80. The company's fourth quarter earnings improved from the year-ago quarter and were above Wall Street view. Net sales rose 15.4 percent and also topped the consensus estimate. The company guided first quarter results in-line with analysts' expectation, but full year earnings per share below Street view.

Optimer Pharmaceuticals, Inc. (OPTR) is rising over 11 percent to $11.95 based on the news that it has started exploring a full range of strategic alternatives. The company also announced that it has appointed its Chairman, Henry McKinnell, as its chief executive, replacing Pedro Lichtinger.

priceline.com Inc. (PCLN) is up 4 percent to $710.00 following the release of its quarterly results.


Target Corp. (TGT) is falling nearly 3 percent to $62.30. The company's fourth quarter profit declined from the year-ago quarter. Total revenues for the quarter rose and managed to come above the consensus estimate. Meanwhile, the company forecast first quarter and 2013 adjusted earnings per share above market view.

First Solar, Inc. (FSLR) is plunging 14 percent to $26.83 following the release of its fourth quarter results.

Trading halt:

Trading in shares of Federal-Mogul Corp. (FDML) was halted. The company slipped to a loss in its fourth quarter on an adjusted basis, reflecting lower sales, especially in the European market.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Trade DLTR now with 
Follow RTT